Search Results - "Nemo, G. J"

Refine Results
  1. 1

    Highly active antiretroviral therapy decreases Mortality and morbidity in patients with advanced HIV disease by MURPHY, Edward L, COLLIER, Ann C, KALISH, Leslie A, ASSMANN, Susan F, PARA, Michael F, FLANIGAN, Timothy P, KUMAR, Princy N, MINTZ, Letty, WALLACH, Frances R, NEMO, George J

    Published in Annals of internal medicine (03-07-2001)
    “…Mortality and morbidity related to AIDS have decreased among HIV-infected patients taking highly active anti-retroviral therapy (HAART), but previous studies…”
    Get full text
    Journal Article
  2. 2

    Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors by Pellett, P.E., Wright, D.J., Engels, E.A., Ablashi, D.V., Dollard, S.C., Forghani, B., Glynn, S.A., Goedert, J.J., Jenkins, F.J., Lee, T.-H., Neipel, F., Todd, D.S., Whitby, D., Nemo, G.J., Busch, M.P.

    Published in Transfusion (Philadelphia, Pa.) (01-09-2003)
    “…BACKGROUND:  As part of assessing the possibility of transfusion transmission of human herpesvirus 8 (HHV‐8 or Kaposi's sarcoma‐associated herpesvirus), HHV‐8…”
    Get full text
    Journal Article
  3. 3

    Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine by Mofenson, Lynne M, Lambert, John S, Stiehm, E. Richard, Bethel, James, Meyer, William A, Whitehouse, Jean, Moye, John, Reichelderfer, Patricia, Harris, D. Robert, Fowler, Mary Glenn, Mathieson, Bonnie J, Nemo, George J

    Published in The New England journal of medicine (05-08-1999)
    “…Several studies have identified maternal, obstetrical, and infant characteristics associated with perinatal transmission of human immunodeficiency virus type 1…”
    Get full text
    Journal Article
  4. 4

    An ELISA for Detection of Antibodies to the E2 Protein of GB Virus C by Dille, Bruce J., Surowy, Teresa K., Gutierrez, Robin A., Coleman, Paul F., Knigge, Mark F., Carrick, Robert J., Aach, Richard D., Hollinger, F. Blaine, Stevens, Cladd E., Barbosa, Luiz H., Nemo, George J., Mosley, James W., Dawson, George J., Mushahwar, Isa K.

    Published in The Journal of infectious diseases (01-02-1997)
    “…An ELISA was developed for detection of antibodies to GB virus C (GBV-C)using a recombinant E2 protein expressed in CHO cells. Seroconversion to anti-E2…”
    Get full text
    Journal Article
  5. 5

    The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion by Kleinman, S.H., Glynn, S.A., Higgins, M.J., Triulzi, D.J., Smith, J.W., Nass, C.C., Garratty, George, Murphy, E.L., LeParc, G.F., Schreiber, G.B., King, M.R., Chamberland, M.E., Nemo, G.J.

    Published in Transfusion (Philadelphia, Pa.) (01-07-2005)
    “…BACKGROUND: An ongoing issue in transfusion medicine is whether newly identified or emerging pathogens can be transmitted by transfusion. One method to study…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Hepatitis C Virus Infection in Post-Transfusion Hepatitis: An Analysis with First- and Second-Generation Assays by Aach, Richard D, Stevens, Cladd E, Hollinger, F. Blaine, Mosley, James W, Peterson, David A, Taylor, Patricia E, Johnson, Rhonda G, Barbosa, Luiz H, Nemo, George J

    Published in The New England journal of medicine (07-11-1991)
    “…ALTHOUGH non-A, non-B hepatitis was first recognized in 1974, 1 , 2 identification of the responsible etiologic agent or agents proved difficult. Prospective…”
    Get full text
    Journal Article
  8. 8

    Increased Prevalence of Infectious Diseases and Other Adverse Outcomes in Human T Lymphotropic Virus Types I- and II-Infected Blood Donors by Murphy, Edward L., Glynn, Simone A., Fride, Joy, Sacher, Ronald A., Smith, James W., Wright, David J., Newman, Bruce, Gibble, Joan W., Ameti, Dannie I., Nemo, George J.

    Published in The Journal of infectious diseases (01-12-1997)
    “…Disease associations of human T lymphotropic virus types I and II (HTLV-I and -II) infection were studied in 154 HTLV-I-infected, 387 HTLV-II-infected, and 799…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients by Mosley, J W, Stevens, C E, Aach, R D, Hollinger, F B, Mimms, L T, Solomon, L R, Barbosa, L H, Nemo, G J

    Published in Transfusion (Philadelphia, Pa.) (01-01-1995)
    “…Testing for antibody to hepatitis B core antigen (anti-HBc) as a surrogate for hepatitis C viremia is no longer needed for blood donor screening. Currently,…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Risk factors for hepatitis C virus infection in United States blood donors by Murphy, Edward L., Bryzman, Stephen M., Glynn, Simone A., Ameti, Dannie I., Thomson, Ruth A., Williams, Alan E., Nass, Catharie C., Ownby, Helen E., Schreiber, George B., Kong, Fanhui, Neal, Keith R., Nemo, George J.

    Published in Hepatology (Baltimore, Md.) (01-03-2000)
    “…Injection drug use (IDU) is a known risk factor for hepatitis C virus (HCV) infection, but the strength of other parenteral and sexual risk factors is unclear…”
    Get full text
    Journal Article
  15. 15

    Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes by Mosley, J W, Huang, W, Stram, D O, Nowicki, M J, Hollinger, F B, Aach, R D, Stevens, C E, Barbosa, L H, Nemo, G J

    Published in Transfusion (Philadelphia, Pa.) (01-09-1996)
    “…Hepatitis virus(es) that are neither hepatitis B (HBV) nor hepatitis C (HCV) (non-B, non-C [NBNC]) may be transmitted by transfusion. The present study…”
    Get more information
    Journal Article
  16. 16

    Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors by Korelitz, J J, Busch, M P, Kleinman, S H, Williams, A E, Zuck, T F, Gilcher, R O, Ownby, H E, Co Chien, H, Nemo, G J

    Published in Transfusion (Philadelphia, Pa.) (01-03-1996)
    “…The value of the test for antibody to hepatitis B core antigen (anti-HBc) as a surrogate screening assay in the time before sensitive, virus-specific screening…”
    Get more information
    Journal Article
  17. 17

    Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository by Kleinman, S H, Niland, J C, Azen, S P, Operskalski, E A, Barbosa, L H, Chernoff, A I, Edwards, V M, Lenes, B A, Marshall, G J, Nemo, G J

    Published in Transfusion (Philadelphia, Pa.) (01-09-1989)
    “…The Transfusion Safety Study (TSS) and the National Heart, Lung, and Blood Institute (NHLBI) established a repository of approximately 200,000 sera from blood…”
    Get more information
    Journal Article
  18. 18

    Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection by MIMMS, L. T, MOSLEY, J. W, HOLLINGER, F. B, AACH, R. D, STEVENS, C. E, CUNNINGHAM, M, VALLARI, D. V, BARBOSA, L. H, NEMO, G. J

    “…A study was conducted to investigate the possible interference with acute hepatitis B virus infection by co-infection with hepatitis C virus…”
    Get full text
    Journal Article
  19. 19

    HIV Testing: State of the Art by Sloand, Elaine M, Pitt, Elisabeth, Chiarello, Robert J, Nemo, George J

    “…TECHNOLOGY for detecting the antibody to human immunodeficiency virus type 1 (HIV-1), the etiologic agent of the acquired immunodeficiency syndrome (AIDS), was…”
    Get full text
    Journal Article
  20. 20

    Antigenic relationship of human foamy virus to the simian foamy viruses by Nemo, G J, Brown, P W, Gibbs, Jr, C J, Gajdusek, D C

    Published in Infection and Immunity (01-04-1978)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article